CHRONIC LYMPHOCYTIC LEUKAEMIA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKAEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKAEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart-Safe cancer drug trial offers hope for vulnerable patients
Disease control Recruiting nowThis study is testing whether a leukemia drug called acalabrutinib is safe for people who also have moderate to severe heart problems. Researchers will compare it to other standard treatments to see which causes fewer heart-related side effects. The trial will enroll 60 adults wi…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial targets tough blood cancers after other treatments fail
Disease control Recruiting nowThis study is testing an oral drug called nemtabrutinib in people with several types of advanced blood cancers that have come back or stopped responding to other treatments. It aims to find a safe and effective dose and see how well the drug shrinks tumors and controls the diseas…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New hope for Tough-to-Treat blood cancers in early trial
Disease control Recruiting nowThis early-stage study is testing a new drug called AZD0486, both alone and combined with other cancer treatments, for people with advanced B-cell blood cancers that have returned or stopped responding to prior therapies. It aims to find a safe dose and see if the drug can shrink…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Gene therapy patients with new cancers sought for testing
Knowledge-focused Recruiting nowThis study is a testing service, not a treatment. It aims to analyze tumor samples from patients who received a specific Bristol-Myers Squibb gene therapy for blood cancers and later developed a second, unrelated cancer. The goal is to check if genetic material from the original …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKAEMIA
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Mar 11, 2026 14:53 UTC